Tumor-Associated CD68+, CD163+, and MARCO+ Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma

Tumor-Associated CD68+, CD163+, and MARCO+ Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma

Background: Despite improvements in surgical methodologies and perioperative chemo- and radiotherapy, the prognosis for patients with esophageal and gastric cancer remains poor. Hence, there is a great need to identify complementary biomarkers for improved treatment stratification. Tumor-infiltratin...

Full description

Bibliographic Details
Main Authors: Martin Jeremiasen, David Borg, Charlotta Hedner, Maria Svensson, Björn Nodin, Karin Leandersson, Jan Johansson, Karin Jirström
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
esophageal cancer
gastric cancer
macrophages
prognosis
treatment naïve
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.534761/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.534761/full

Similar Items